Evidence map›Paper›PMID 34381441›Full record

ArticleFrontiers in immunology2021

A20 Establishes Negative Feedback With TRAF6/NF-κB and Attenuates Early Brain Injury After Experimental Subarachnoid Hemorrhage.

Hong-Ji Deng, QuZhen Deji, WangDui Zhaba, Jia-Qiang Liu, Sheng-Qing Gao, Yan-Ling Han, Meng-Liang Zhou, Chun-Xi Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Meningeal lymphatic dysfunction drives cognitive impairment after experimental subarachnoid hemorrhage.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  6. Article
  7. The Ubiquitin-Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  8. Article
  9. Exosomal CircMFN2 Enhances the Progression of Pituitary Adenoma via the MiR-146a-3p/TRAF6/NF-κB Pathway.Journal of neurological surgery. Part A, Central European neurosurgery · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Hong-Ji DengDepartment of Neurosurgery, The First Affiliated Hospital, Guangxi Medical University, Nanning, China.
QuZhen DejiDepartment of Ophthalmology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
WangDui ZhabaDepartment of Neurosurgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Jia-Qiang LiuDepartment of Neurosurgery, Yijishan Hospital, Wannan Medical College, Wuhu, China.
Sheng-Qing GaoDepartment of Neurosurgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yan-Ling HanDepartment of Neurosurgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Meng-Liang ZhouDepartment of Neurosurgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Chun-Xi WangDepartment of Neurosurgery, The First Affiliated Hospital, Guangxi Medical University, Nanning, China.
Nanjing General Hospital of Nanjing Military Command · CNNanjing Medical University · CNFirst Affiliated Hospital of GuangXi Medical University · CNFirst Affiliated Hospital of Wannan Medical College · CNGuangxi Medical University · CNNanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear factor (NF)-κB-ty -50mediated neuroinflammation plays a crucial role in early brain injury (EBI) after subarachnoid hemorrhage (SAH). As an important negative feedback regulator of NF-κB, A20 is essential for inflammatory homeostasis. Herein, we tested the hypothesis that A20 attenuates EBI by establishing NF-κB-associated negative feedback after experimental SAH.

Indexed as

AnimalsBrainCells, CulturedCytokinesFeedback, PhysiologicalHumansInflammation MediatorsMaleMiceMice, Inbred C57BLModels, AnimalNF-kappa BSignal TransductionSubarachnoid HemorrhageTNF Receptor-Associated Factor 6Tumor Necrosis Factor alpha-Induced Protein 3CytokinesInflammation MediatorsNF-kappa BTnfaip3 protein, mouseTNF Receptor-Associated Factor 6Tumor Necrosis Factor alpha-Induced Protein 3A20neuroinflammationNF-κBsubarachnoid hemorrhageTRAF6

Identifiers

PMID34381441
PMCPMC8350325
OpenAlexW3183624257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.